SAGE PRO

Home / Research / Cemindia Projects Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

Cemindia Projects Limited — Q2 FY27 Results Analysis

25% revenue growth

Published · Quarter Q2 FY27 · CEMPRO

PeriodQ2 FY27
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Quarterly revenue

Q2 FY26₹2,195 crore
Q2 FY27₹2,749 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312d8489-862d-450c-84e5-00e186e00f1d.pdf

CHART 2

Quarterly EBITDA

Q2 FY26₹243 crore
Q2 FY27₹280 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312d8489-862d-450c-84e5-00e186e00f1d.pdf

CHART 3

Quarterly EBITDA margin

Q2 FY2611.1%
Q2 FY2710.2%

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312d8489-862d-450c-84e5-00e186e00f1d.pdf

CHART 4

Quarterly PAT

Q2 FY26₹108 crore
Q2 FY27₹131 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312d8489-862d-450c-84e5-00e186e00f1d.pdf

ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

25% revenue growth

Quarterly revenue changed from 2195 ₹ crore (Q2 FY26) to 2749 ₹ crore (Q2 FY27). 25% revenue growth.

Watch: Check execution milestones

RESEARCH INSIGHT

15% profit growth lagged sales

Quarterly EBITDA changed from 243 ₹ crore (Q2 FY26) to 280 ₹ crore (Q2 FY27). 15% profit growth lagged sales.

Watch: Audit contract costs

RESEARCH INSIGHT

Margin compressed by 90 basis points

Quarterly EBITDA margin changed from 11.1 % (Q2 FY26) to 10.2 % (Q2 FY27). Margin compressed by 90 basis points.

Watch: Track project mix

RESEARCH INSIGHT

PAT grew 21%

Quarterly PAT changed from 108 ₹ crore (Q2 FY26) to 131 ₹ crore (Q2 FY27). PAT grew 21%.

Watch: Reconcile tax and financing

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

Quarter ended 30 September 2026 · Stance WATCH · original issuer/exchange sources. The Q2 revenue expansion reflects project execution, not a guaranteed conversion of the huge orderbook into free cash. At ₹2,749 crore quarterly sales against ₹280 crore EBITDA the investment case is about contract profitability, receivable certification and net-debt control. Management raised ₹1,400 crore through a QIP and reported a ₹32,715 crore backlog, so investors should assess returns on both the enlarged equity base and unexecuted projects rather than treating new funding as profit. [S1][S2]

Decision metricEarlier referenceLatest reference
Quarterly revenue2195 ₹ crore (Q2 FY26)2749 ₹ crore (Q2 FY27)
Quarterly EBITDA243 ₹ crore (Q2 FY26)280 ₹ crore (Q2 FY27)
Quarterly EBITDA margin11.1 % (Q2 FY26)10.2 % (Q2 FY27)
Quarterly PAT108 ₹ crore (Q2 FY26)131 ₹ crore (Q2 FY27)
Half-year sales4772 ₹ crore (H1 FY26)5470 ₹ crore (H1 FY27)
Half-year EBITDA504 ₹ crore (H1 FY26)565 ₹ crore (H1 FY27)
Half-year margin10.6 % (H1 FY26)10.3 % (H1 FY27)
Half-year PAT245 ₹ crore (H1 FY26)271 ₹ crore (H1 FY27)

Key takeaways: Quarterly revenue: 25% revenue growth. Quarterly EBITDA: 15% profit growth lagged sales. Quarterly EBITDA margin: Margin compressed by 90 basis points. Quarterly PAT: PAT grew 21%. Half-year sales: Six-month revenue rose 15%. Half-year EBITDA: Half-year EBITDA rose 12%. All comparisons follow the issuer's specified dates, basis and units. The separate graphical Investment Briefing precedes the detailed main report.

Chapter 1 — Investment decision and valuation burden

The Q2 revenue expansion reflects project execution, not a guaranteed conversion of the huge orderbook into free cash. At ₹2,749 crore quarterly sales against ₹280 crore EBITDA the investment case is about contract profitability, receivable certification and net-debt control. Management raised ₹1,400 crore through a QIP and reported a ₹32,715 crore backlog, so investors should assess returns on both the enlarged equity base and unexecuted projects rather than treating new funding as profit. [S1][S2]

Issuer-specific financial checks and decisions

  • Quarterly revenue: 2749 ₹ crore (Q2 FY27) against 2195 ₹ crore (Q2 FY26). 25% revenue growth; Check execution milestones. [S2]
  • Quarterly EBITDA: 280 ₹ crore (Q2 FY27) against 243 ₹ crore (Q2 FY26). 15% profit growth lagged sales; Audit contract costs. [S2]
  • Quarterly EBITDA margin: 10.2 % (Q2 FY27) against 11.1 % (Q2 FY26). Margin compressed by 90 basis points; Track project mix. [S2]

Monitoring interpretation. 25% revenue growth. The practical next-quarter test is: check execution milestones. 15% profit growth lagged sales. The practical next-quarter test is: audit contract costs. Margin compressed by 90 basis points. The practical next-quarter test is: track project mix. These observations help distinguish underlying operating economics from stated management ambitions; they do not establish an unreported entry price, dividend, free cash flow or earnings forecast.

Chapter 2 — Quarter and H1 financials and earnings quality

Q2 revenue of ₹2,749 crore rose from ₹2,195 crore, while EBITDA rose from ₹243 crore to ₹280 crore. The 10.2% quarterly EBITDA margin is below 11.1% a year earlier. H1 revenue of ₹5,470 crore improved from ₹4,772 crore; H1 EBITDA ₹565 crore was up from ₹504 crore. H1 PAT ₹271 crore rose from ₹245 crore. The mismatch between top-line growth and margin is more decision-useful than a record-revenue headline, because contract costs and completion schedules can vary widely. [S1][S2]

Issuer-specific financial checks and decisions

  • Quarterly EBITDA margin: 10.2 % (Q2 FY27) against 11.1 % (Q2 FY26). Margin compressed by 90 basis points; Track project mix. [S2]
  • Quarterly PAT: 131 ₹ crore (Q2 FY27) against 108 ₹ crore (Q2 FY26). PAT grew 21%; Reconcile tax and financing. [S2]
  • Half-year sales: 5470 ₹ crore (H1 FY27) against 4772 ₹ crore (H1 FY26). Six-month revenue rose 15%; Track H2 certifications. [S2]

Monitoring interpretation. Margin compressed by 90 basis points. The practical next-quarter test is: track project mix. PAT grew 21%. The practical next-quarter test is: reconcile tax and financing. Six-month revenue rose 15%. The practical next-quarter test is: track h2 certifications. These observations help distinguish underlying operating economics from stated management ambitions; they do not establish an unreported entry price, dividend, free cash flow or earnings forecast.

Chapter 3 — Product, segment and channel economics

Cemindia is an engineering contractor in maritime, metro, urban, industrial and other infrastructure work. The issuer described more than 80 projects across eight sectors and roughly 99% domestic geographic exposure. An EPC contract's profitability depends on escalation provisions, supplier prices, site utilization and customer milestone certification. Backlog is a mixture of future earning opportunities, not the equivalent of already earned operating revenue. [S1][S2]

Issuer-specific financial checks and decisions

  • Half-year sales: 5470 ₹ crore (H1 FY27) against 4772 ₹ crore (H1 FY26). Six-month revenue rose 15%; Track H2 certifications. [S2]
  • Half-year EBITDA: 565 ₹ crore (H1 FY27) against 504 ₹ crore (H1 FY26). Half-year EBITDA rose 12%; Check overhead absorption. [S2]
  • Half-year margin: 10.3 % (H1 FY27) against 10.6 % (H1 FY26). H1 margin also slipped; Avoid margin assumptions. [S2]

Monitoring interpretation. Six-month revenue rose 15%. The practical next-quarter test is: track h2 certifications. Half-year EBITDA rose 12%. The practical next-quarter test is: check overhead absorption. H1 margin also slipped. The practical next-quarter test is: avoid margin assumptions. These observations help distinguish underlying operating economics from stated management ambitions; they do not establish an unreported entry price, dividend, free cash flow or earnings forecast.

Chapter 4 — Execution promises, milestones and Q&A challenges

The presentation highlighted ₹12,005 crore of orders secured in H1, a ₹32,715 crore book at 30 September and credit-rating upgrades. QIP proceeds of ₹1,400 crore expand financial flexibility but are a capital transaction. Execution milestones and contract profitability are separate from order-win publicity. Analyst questions should address billing milestones, overruns, retention, project risk concentration, and the timing of collections from government and private clients. [S1][S2]

Issuer-specific financial checks and decisions

  • Half-year margin: 10.3 % (H1 FY27) against 10.6 % (H1 FY26). H1 margin also slipped; Avoid margin assumptions. [S2]
  • Half-year PAT: 271 ₹ crore (H1 FY27) against 245 ₹ crore (H1 FY26). Six-month PAT rose 11%; Compare operating cash. [S2]
  • Balance sheet net debt: 773 ₹ crore (30 Sep 2026) against 527 ₹ crore (Earlier FY26 reference). Debt rose on referenced dates; Track credit and collections. [S2]

Monitoring interpretation. H1 margin also slipped. The practical next-quarter test is: avoid margin assumptions. Six-month PAT rose 11%. The practical next-quarter test is: compare operating cash. Debt rose on referenced dates. The practical next-quarter test is: track credit and collections. These observations help distinguish underlying operating economics from stated management ambitions; they do not establish an unreported entry price, dividend, free cash flow or earnings forecast.

Chapter 5 — Operating cash, capex, debt and payback

Management cited net debt ₹773 crore and net worth ₹2,619 crore as of September, about 0.3x net debt/equity, while earlier debt was ₹527 crore. Cash flows in construction move with customer advances, receivables and retention money. Until a full cash-flow bridge and contract-specific payback is available, no free-cash-flow yield or forecast debt paydown can be asserted. QIP issuance also changes per-share comparisons. [S1][S2]

Issuer-specific financial checks and decisions

  • Balance sheet net debt: 773 ₹ crore (30 Sep 2026) against 527 ₹ crore (Earlier FY26 reference). Debt rose on referenced dates; Track credit and collections. [S2]
  • Net worth: 2619 ₹ crore (30 Sep 2026) against 2400 ₹ crore (Earlier FY26 reference). Equity base grew; Measure return on equity. [S2]
  • H1 awards versus backlog: 32715 ₹ crore (30 Sep backlog) against 12005 ₹ crore (H1 orders). Awards and orderbook differ in nature; Reconcile executed works. [S2]

Monitoring interpretation. Debt rose on referenced dates. The practical next-quarter test is: track credit and collections. Equity base grew. The practical next-quarter test is: measure return on equity. Awards and orderbook differ in nature. The practical next-quarter test is: reconcile executed works. These observations help distinguish underlying operating economics from stated management ambitions; they do not establish an unreported entry price, dividend, free cash flow or earnings forecast.

Chapter 6 — Bull, base and bear conditional scenarios

Bull conditions involve profitable conversion of existing backlog, higher certified execution and recovery toward an 11% EBITDA margin while debt is controlled. A base case has sustained sales with margin fluctuations and working-capital absorption. Bear conditions involve delayed site work, payments, subcontract cost overruns or additional equity/debt required without acceptable return. These are conditional outcomes, not probability-weighted stock-price forecasts. [S1][S2]

Issuer-specific financial checks and decisions

  • Quarterly revenue: 2749 ₹ crore (Q2 FY27) against 2195 ₹ crore (Q2 FY26). 25% revenue growth; Check execution milestones. [S2]
  • Quarterly EBITDA: 280 ₹ crore (Q2 FY27) against 243 ₹ crore (Q2 FY26). 15% profit growth lagged sales; Audit contract costs. [S2]
  • Quarterly EBITDA margin: 10.2 % (Q2 FY27) against 11.1 % (Q2 FY26). Margin compressed by 90 basis points; Track project mix. [S2]

Monitoring interpretation. 25% revenue growth. The practical next-quarter test is: check execution milestones. 15% profit growth lagged sales. The practical next-quarter test is: audit contract costs. Margin compressed by 90 basis points. The practical next-quarter test is: track project mix. These observations help distinguish underlying operating economics from stated management ambitions; they do not establish an unreported entry price, dividend, free cash flow or earnings forecast.

Chapter 7 — Investor action plan and quarterly monitoring

WATCH until H2 delivers margin stabilization and receivable/cash discipline. Monitor ₹2,749 crore quarterly revenue, 10.2% margin, ₹32,715 crore unexecuted backlog, the ₹12,005 crore H1 order intake, the ₹1,400 crore QIP and ₹773 crore net debt. Require a roll-forward of backlog and certified billing, not gross orders alone. Upgrade only on better project economics and cash conversion; downgrade if customer delays or debt accumulation persist. [S1][S2]

Issuer-specific financial checks and decisions

  • Quarterly EBITDA margin: 10.2 % (Q2 FY27) against 11.1 % (Q2 FY26). Margin compressed by 90 basis points; Track project mix. [S2]
  • Quarterly PAT: 131 ₹ crore (Q2 FY27) against 108 ₹ crore (Q2 FY26). PAT grew 21%; Reconcile tax and financing. [S2]
  • Half-year sales: 5470 ₹ crore (H1 FY27) against 4772 ₹ crore (H1 FY26). Six-month revenue rose 15%; Track H2 certifications. [S2]

Monitoring interpretation. Margin compressed by 90 basis points. The practical next-quarter test is: track project mix. PAT grew 21%. The practical next-quarter test is: reconcile tax and financing. Six-month revenue rose 15%. The practical next-quarter test is: track h2 certifications. These observations help distinguish underlying operating economics from stated management ambitions; they do not establish an unreported entry price, dividend, free cash flow or earnings forecast.

Supporting issuer and exchange filings

[S1] Cemindia Projects Limited Q2 FY27 earnings-call transcript — management discussion and analyst questions for the September 2026 quarter. [S2] Cemindia Projects Limited Q2 and H1 FY27 investor presentation — issuer financial and operating data.

Interpretive limits: Future product launches, order contracts, customer discussions, raw-material effects and project milestones are cited as management commentary where relevant, not realized future profits. Valuation figures, project payback, market prices, leverage and cash conversions are omitted where the saved issuer evidence is inadequate.

Additional company evidence

CHART 5

Half-year sales

H1 FY26₹4,772 crore
H1 FY27₹5,470 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312d8489-862d-450c-84e5-00e186e00f1d.pdf

CHART 6

Half-year EBITDA

H1 FY26₹504 crore
H1 FY27₹565 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312d8489-862d-450c-84e5-00e186e00f1d.pdf

CHART 7

Half-year margin

H1 FY2610.6%
H1 FY2710.3%

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312d8489-862d-450c-84e5-00e186e00f1d.pdf

CHART 8

Half-year PAT

H1 FY26₹245 crore
H1 FY27₹271 crore

https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=312d8489-862d-450c-84e5-00e186e00f1d.pdf

SOURCE REFERENCES

Original disclosures and investor presentations

  1. Issuer disclosure
  2. Issuer disclosure

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.